IP Library › Granted Patent US 12,605,078
Granted Patent B2
US 12,605,078 · App. 18/050,756 · Granted Apr 21, 2026

Method and apparatus for continuous vitals monitoring

Inventor: Manojeet Bhattacharya (Edina, MN)
Assignee: Rythmos LLC
A61B5/02055A61B5/14532A61B5/14552A61B5/681A61B5/7425A61B5/021A61B5/02427A61B2560/0223A61B2562/0233
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,605,078
App. No.
18/050,756
Granted
Apr 21, 2026
Kind
B2
Abstract

A health monitoring device for detecting a physiological attribute having a physiological attribute sensor including a first fiber Bragg grating (FBG) with a refractive index is configured to be placed in contact with a person's skin approximate to an artery or vein. A baseline sensor that includes a second fiber Bragg grating (FBG) also having a refractive index is configured to be placed in contact with a person's skin away from an artery or vein to provide a baseline refractive index. The device pulses light waves through the FBGs to provide a processor with reading of the refractive index from the FBGs. Based on the effective shifts of the Bragg wavelength due to axial strain on the FBGs, a physiological attribute estimator estimates a physiological attribute based on a calibration curve comparing a physiological attribute against strain.

Claims (34)

1 . A health monitoring device, comprising:

a blood pressure sensor including a first fiber Bragg grating (FBG) configured to be placed in contact with a person's skin approximate to an artery or vein and having a first Bragg wavelength;

a baseline sensor including a second fiber Bragg grating (FBG) configured to be placed in contact with a person's skin away from the artery or vein and having a second Bragg wavelength and providing a measure of a baseline signal;

a light emitter configured to pulse light waves through the FBGs;

light sensors configured to receive pulsed light waves;

a processor including:

a data acquisition module configured to receive from the light sensor peak wavelengths reflected by the FBGs;

a comparator configured to determine effective shifts of the first Bragg wavelength and effective shifts of the second Bragg wavelength over time; and

a blood pressure estimator configured to estimate systolic and diastolic blood pressure based on 1) the effective shifts of the first Bragg wavelength corrected for drifts in the baseline signal based on the effective shifts of the second Bragg wavelength, and 2) an output of a physiological attribute monitor; and

a display for providing the estimated systolic and diastolic blood pressure.

2 . The device of claim 1 , wherein the blood pressure estimator is configured to estimate the systolic and diastolic blood pressure based on pulse transit times (PTT) between blood pressure pulses from the blood pressure sensor and the output, the output being one of an electrocardiogram (ECG) and a heart rate monitor.

3 . The device of claim 1 , wherein the processor is further configured to determine a pulse pressure waveform based on the effective shifts of the first Bragg wavelength corrected for drifts in the baseline signal based on the effective shifts of the second Bragg wavelengths.

4 . The device of claim 3 , wherein the processor is further configured to analyze pulse pressure waveform features including at least one of a stroke volume and a dicrotic notch.

5 . The device of claim 3 , further comprising a processor configured to analyze the pulse pressure waveform to determine a cardiovascular parameter including at least one of stroke volume and cardiac output.

6 . The device of claim 3 , further comprising a processor configured to perform a pattern recognition analysis of the pulse pressure waveform to estimate a likelihood of a disease exhibited by the person.

7 . The device of claim 1 , implemented in a wearable band at the person's arm or wrist, the first and second FBGs being embedded within a strap of the wearable band.

8 . The device of claim 7 , wherein the physiological attribute monitor is enclosed within the device the physiological attribute monitor including at least one of an ECG, a heartrate monitor, an oxygen saturation (SPO2) monitor, a blood glucose monitor, and a skin temperature monitor.

9 . The device of claim 1 , wherein the blood pressure estimator is configured to estimate the systolic and diastolic blood pressure based on a calibration function is derived from a timing correlation between the blood pressure sensor and an output of the physiological attribute monitor, the output being at least one of an ECG, heart rate, blood oxygen saturation.

10 . The device of claim 1 , wherein the processor further includes a heart rate monitor configured to detect periodic changes in surface deformation associated with a heartbeat.

11 . The device of claim 1 , wherein the physiological attribute monitor measures one of an ECG, blood oxygen saturation, body temperature, and blood glucose.

12 . The device of claim 1 , wherein the display is located on a remote device, and further including a transmitter configured to transmit estimated systolic and diastolic blood pressure to the display.

13 . The device of claim 1 , wherein the blood pressure sensor further includes a plurality of FBGs configured to be placed in contact with a person's skin close approximate to an artery or vein and having Bragg wavelengths, wherein each FBG is displaced from one another by a predetermined amount, and wherein the processor is configured to reconcile acquired data from the plurality of FBGs to optimize a measurement in effective shifts in Bragg wavelength of the blood pressure sensor.

14 . A method of monitoring health, comprising:

pulsing light waves through a first and second fiber Bragg gratings (FBGs) at 1) a blood pressure sensor including a first fiber Bragg grating (FBG) configured to be placed in contact with a person's skin approximate to an artery or vein and having a first Bragg wavelength, and 2) a baseline sensor including a second fiber Bragg grating (FBG) configured to be placed in contact with a person's skin away from the artery or vein and having a second Bragg wavelength and providing a measure of a baseline signal;

obtaining, from a light sensor configured to receive pulsed light waves, peak wavelengths reflected by the first and second FBGs;

determining effective shifts of the first Bragg wavelength and effective shifts of the second Bragg wavelength over time;

estimating systolic and diastolic blood pressure based on 1) the effective shifts of the first Bragg wavelength corrected for drifts in the baseline signal based on the effective shifts of the second Bragg wavelength, and 2) an output of a physiological attribute monitor; and

displaying the estimated systolic and diastolic blood pressure.

15 . The method of claim 14 , wherein estimating the systolic and diastolic blood pressure is based on pulse transit times (PTT) between blood pressure pulses from the blood pressure sensor and the output, the output being one of an electrocardiogram (ECG) and a heart rate monitor.

16 . The method of claim 14 , further comprising determining a pulse pressure waveform based on the effective shifts of the first Bragg wavelength corrected for drifts in the baseline signal based on the effective shifts of the second Bragg wavelengths.

17 . The method of claim 16 , further comprising analyzing pulse pressure waveform features including at least one of a stroke volume and a dicrotic notch.

18 . The method of claim 16 , further comprising analyzing the pulse pressure waveform to determine a cardiovascular parameter including at least one of stroke volume and cardiac output.

19 . The method of claim 16 , further comprising performing a pattern recognition analysis of the pulse pressure waveform to estimate a likelihood of a disease exhibited by the person.

20 . The method of claim 16 , wherein estimating the systolic and diastolic blood pressure is based on a calibration function derived from a timing correlation between the blood pressure sensor and an output of the physiological attribute monitor, the output being at least one of an ECG, heart rate, blood oxygen saturation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2023
From: EMPNIA INC.
To: RYTHMOS LLC
Reel/Frame 064939/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2023
From: BHATTACHARYA, MANOJEET
To: EMPNIA INC.
Reel/Frame 062530/0356 →
Continuity (2)
Continuation In Part 16723078 · Dec 20, 2019
Related Publication 20230070912A1 · Mar 9, 2023
References Cited (129)
US 4868381A · Davis · 1989 [cited by applicant]
US 4909260A · Salem et al. · 1990 [cited by applicant]
US 5545993A · Taguchi et al. · 1996 [cited by applicant]
US 5907403A · Andrews et al. · 1999 [cited by applicant]
US 6475153B1 · Khair et al. · 2002 [cited by applicant]
US 7077810B2 · Lange et al. · 2006 [cited by applicant]
US 7257436B2 · Sasaki et al. · 2007 [cited by applicant]
US 7678063B2 · Felmlee et al. · 2010 [cited by applicant]
US 8553959B2 · Hsieh et al. · 2013 [cited by applicant]
US 8655441B2 · Fletcher et al. · 2014 [cited by applicant]
US 9088130B2 · Kim et al. · 2015 [cited by applicant]
US 9116055B2 · Johnston · 2015 [cited by applicant]
US 9304018B2 · Davis et al. · 2016 [cited by applicant]
US 9730654B2 · Erbel et al. · 2017 [cited by applicant]
US 9841331B2 · Wood et al. · 2017 [cited by applicant]
US 9987503B2 · Grass et al. · 2018 [cited by applicant]
US 10234934B2 · Connor · 2019 [cited by applicant]
US 10321873B2 · Connor · 2019 [cited by applicant]
US 10332644B2 · Garcia · 2019 [cited by applicant]
US 10488916B2 · Hahami et al. · 2019 [cited by applicant]
US 10524701B2 · Kim et al. · 2020 [cited by applicant]
US 10716510B2 · Connor · 2020 [cited by applicant]
US 11041740B1 · Bhattacharya · 2021 [cited by applicant]
US 11504010B2 · Bhattacharya · 2022 [cited by applicant]
US 12044556B2 · Bhattacharya · 2024 [cited by applicant]
US 12209891B2 · Bhattacharya · 2025 [cited by applicant]
US 12209892B1 · Bhattacharya · 2025 [cited by applicant]
US 20050192508A1 · Lange et al. · 2005 [cited by applicant]
US 20080045813A1 · Phuah et al. · 2008 [cited by applicant]
US 20080146947A1 · Kojima et al. · 2008 [cited by applicant]
US 20080300502A1 · Yang et al. · 2008 [cited by applicant]
US 20090185772A1 · Xia et al. · 2009 [cited by applicant]
US 20090234240A1 · Kuenzler et al. · 2009 [cited by applicant]
US 20130035587A1 · Lagendijk et al. · 2013 [cited by applicant]
US 20130211261A1 · Wang et al. · 2013 [cited by applicant]
US 20140064332A1 · Johnston · 2014 [cited by applicant]
US 20140088377A1 · Manske et al. · 2014 [cited by applicant]
US 20140128721A1 · Forthmann et al. · 2014 [cited by applicant]
US 20140193058A1 · Bharat et al. · 2014 [cited by applicant]
US 20140194703A1 · Wondka et al. · 2014 [cited by applicant]
US 20140238153A1 · Wood et al. · 2014 [cited by applicant]
US 20140268099A1 · Moslehi · 2014 [cited by applicant]
US 20150018596A1 · Schulz et al. · 2015 [cited by applicant]
US 20150119703A1 · Mitchell et al. · 2015 [cited by applicant]
US 20150124266A1 · Davis et al. · 2015 [cited by applicant]
US 20150289785A1 · Bojovic et al. · 2015 [cited by applicant]
US 20150359455A1 · Hahami et al. · 2015 [cited by applicant]
US 20150359467A1 · Tran · 2015 [cited by applicant]
US 20160202755A1 · Connor · 2016 [cited by applicant]
US 20160256710A1 · Goldstein et al. · 2016 [cited by applicant]
US 20160338644A1 · Connor · 2016 [cited by applicant]
US 20160361194A1 · Hautvast et al. · 2016 [cited by applicant]
US 20170007849A1 · Hautvast et al. · 2017 [cited by applicant]
US 20170049341A1 · Karabacak et al. · 2017 [cited by applicant]
US 20170354353A1 · Kim et al. · 2017 [cited by applicant]
US 20180008196A1 · Connor · 2018 [cited by applicant]
US 20180364115A1 · Brown et al. · 2018 [cited by applicant]
US 20190223782A1 · Wen et al. · 2019 [cited by applicant]
US 20190298265A1 · Keating et al. · 2019 [cited by applicant]
US 20190336038A1 · Gorgutsa et al. · 2019 [cited by applicant]
US 20210186340A1 · Bhattacharya · 2021 [cited by applicant]
US 20210190549A1 · Bhattacharya · 2021 [cited by applicant]
US 20210223068A1 · Bhattacharya · 2021 [cited by applicant]
US 20240032816A1 · Bhattacharya · 2024 [cited by applicant]
US 20240210218A1 · Bhattacharya · 2024 [cited by applicant]
US 20250003774A1 · Bhattacharya · 2025 [cited by applicant]
US 20250020491A1 · Bhattacharya · 2025 [cited by applicant]
US 20250172414A1 · Bhattacharya · 2025 [cited by applicant]
US 20250172415A1 · Bhattacharya · 2025 [cited by applicant]
CN 103596494A · 2014 [cited by applicant]
CN 103607949A · 2014 [cited by applicant]
CN 103889259A · 2014 [cited by applicant]
CN 103889506A · 2014 [cited by applicant]
CN 106029172A · 2016 [cited by applicant]
CN 110192854A · 2019 [cited by applicant]
CN 110301906A · 2019 [cited by applicant]
CN 209574670U · 2019 [cited by applicant]
CN 111317481A · 2020 [cited by applicant]
JP H0775627A · 1995 [cited by applicant]
JP 2002175582A · 2002 [cited by applicant]
JP 2007185300A · 2007 [cited by applicant]
JP 2007525267A · 2007 [cited by applicant]
JP 2007537777A · 2007 [cited by applicant]
JP 2009501557A · 2009 [cited by applicant]
JP 2011509764A · 2011 [cited by applicant]
JP 2014525764A · 2014 [cited by applicant]
JP 2015231512A · 2015 [cited by applicant]
JP 2017506543A · 2017 [cited by applicant]
JP 2017506555A · 2017 [cited by applicant]
JP 2017519221A · 2017 [cited by applicant]
WO WO02069878A2 · 2002 [cited by applicant]
WO WO2012168836A2 · 2012 [cited by applicant]
WO 2013180085A1 · 2013 [cited by applicant]
WO WO2015128179A1 · 2015 [cited by applicant]
WO WO2015128392A1 · 2015 [cited by applicant]
WO 2015167340A1 · 2015 [cited by applicant]
WO WO2016070099A1 · 2016 [cited by applicant]
WO WO2016147795A1 · 2016 [cited by applicant]
WO 2017037479A1 · 2017 [cited by applicant]
WO WO2017190085A1 · 2017 [cited by applicant]
WO WO2019031041A1 · 2019 [cited by applicant]
WO WO2020049291A1 · 2020 [cited by applicant]
WO WO2021127207A1 · 2021 [cited by applicant]
WO WO2021127233A1 · 2021 [cited by applicant]
WO WO2022020519A1 · 2022 [cited by applicant]
ZA 200508066B · 2007 [cited by applicant]
Anzai Medical, Co., Ltd, “Respiratory Gating System AZ-733V1: What is a Respiratory Gating System,” [retrieved online Jan. 10, 2024] http://www.anzai-med.co.jp, publication date unknown, 4 pages. [cited by applicant]
De Jonckheere, J., et al.; “OFSETH: A breathing motions monitoring system for patients under MRI,” 32nd Annual International Conference of the IEEE EMBS, 2010, pp. 1016-1019. [cited by applicant]
Extended European Search Report for European Application No. 21845416.3, mailed Jun. 14, 2024, 8 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2021/042641, mailed Jan. 24, 2023, 13 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2021/042641, mailed Nov. 12, 2021, 14 pages. [cited by applicant]
Lau, Doreen, et al. “Intensity-Modulated Microbend Fiber Optic Sensor for Respiratory Monitoring and Gating During MRI,” IEEE Transactions on Biomedical Engineering, vol. 60, No. 9, Sep. 2013, pp. 2655-2662. [cited by applicant]
Lui, J. et al, “Evaluation of the combined use of two different respiratory monitoring systems for 4D CT simulation and gated treatment,” Journal of Applied Clinical Medical Physics, Wiley 19:5 pp. 666-675, (2018). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/723,078 dated Mar. 3, 2022, 13 pages. [cited by applicant]
Office Action for Japanese Application No. 2022-538268, mailed Oct. 29, 2024, with English translation, 7 pages. [cited by applicant]
Davies, J. et al, “Beyond blood pressure: pulse wave analysis—a better way of assessing cardiovascular risk?” Future Cardiology, 1(1):69-78 (2005). [cited by applicant]
Esper, S. A., et al, “Arterial waveform analysis,” Best Practice & Research Clinical Anaesthesiology, 28:363-380 (2014). [cited by applicant]
Khan, Y., et al, “A Flexible Organic Reflectance Oximeter Array,” Proceedings of the National Academy of Sciences, 115(47):E11015-E11024 (Nov. 2018). [cited by applicant]
Lee, H. et al, “Reflectance pulse oximetry: Practical issues and limitation,” The Korean Institute of Communications and Information Services, ScienceDirect; 195-198 (Nov. 2016). [cited by applicant]
Nekic, P., “Pulse Contour Cardiac Output (PiCCO) Learning Package,” Liverpool Hospital Intensive Care Unit, pp. 1-17; (Feb. 29, 2016). [cited by applicant]
Roylance, D., “Stress-Strain Curves,” Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, pp. 1-15, (Aug. 23, 2001). [cited by applicant]
International Search Report and Written Opinion for Int'l Application No. PCT/US2020/065652, titled: Wearable Health Monitoring Device, Date Mailed: Mar. 10, 2021. [cited by applicant]
Katsuragawa, Y. and Ishizawa, H., “Non-invasive Blood Pressure Measurement by Pulse Wave Analysis Using FBG Sensor,” 2015 IEEE International Instrumentation and Measurement Technology Conference (12MTC) Proceedings, IEE… [cited by applicant]
Office Action for Chinese Application No. 202080087960.X, with English translation, dated Mar. 28, 2025, 11 pages. [cited by applicant]
Office Action for Chinese Application No. 202180049514.4, with English translation, dated Mar. 14, 2025, 21 pages. [cited by applicant]
Office Action for Japanese Application No. 2023-504460, dated Mar. 24, 2025, mailed May 27, 2025, with Search Report and English translation, 41 pages. [cited by applicant]
CN Application No. 202180049514.4, Office Action and Search Report mailed Oct. 29, 2025; Applicant Rythmos LLC, with English translation; 20 pages. [cited by applicant]
EP Application No. 25167563.3, Extended European Search Report mailed Oct. 22, 2025; Applicant Rythmos LLC; 11 pages. [cited by applicant]
U.S. Appl. No. 18/006,144, Non-Final Office Action mailed Aug. 22, 2025; Inventor Bhattacharya, Manojeet et al.; 28 pages. [cited by applicant]